Skip to main content
Steven Pavletic, MD, Oncology, Bethesda, MD

StevenZPavleticMD

Oncology Bethesda, MD

Hematologic Oncology

Physician

Dr. Pavletic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pavletic's full profile

Already have an account?

  • Office

    10 Center Dr
    Bethesda, MD 20892
    Phone+1 301-402-4899

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1992 - 1995
  • University of Zagreb Faculty of Medicine
    University of Zagreb Faculty of MedicineClass of 1979

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 1993 - 2026

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected Patients  
    Lauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature
  • The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled Trial  
    Annie Im, Steven Z Pavletic, Haematologica

Abstracts/Posters

  • Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy
    Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)
    Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd
    Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Press Mentions

  • GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement Award
    GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023
  • The Future of Chronic Graft-Versus-Host Disease
    The Future of Chronic Graft-Versus-Host DiseaseFebruary 1st, 2021
  • New Drugs Aim to Disarm the Immune System’s ‘Atomic Bomb’ Cells
    New Drugs Aim to Disarm the Immune System’s ‘Atomic Bomb’ CellsMarch 5th, 2020
  • Join now to see all

Professional Memberships